Cambridge Investment Research Advisors’s Arteris AIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$402K Sell
8,269
-10,293
-55% -$329K ﹤0.01% 3169
2026
Q1
$305K Buy
+18,562
New +$294K ﹤0.01% 3265
2025
Q3
– Sell
-21,984
Closed -$210K – 3718
2025
Q2
$210K Buy
21,984
+8,270
+60% +$60.9K ﹤0.01% 3311
2025
Q1
$95K Buy
+13,714
New +$131K ﹤0.01% 3355

Other funds holding AIP

Cambridge Investment Research Advisors's AIP Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Arteris (AIP) stake by 55% in Q2 2026, selling an estimated $329K and leaving 8,269 shares worth $402K. The position accounts for ﹤0.01% of the portfolio, ranked #3169.

Cambridge Investment Research Advisors first reported a position in AIP in Q1 2025 and has held it in 4 quarters since. 211 funds tracked by Wall St. Rank hold AIP as of Q2 2026.

  • Cambridge Investment Research Advisors held 8,269 shares of Arteris worth $402K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 10,293 Arteris shares in Q2 2026, an estimated $329K.
  • Arteris made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3169 holding.
  • Cambridge Investment Research Advisors first reported a position in Arteris in Q1 2025 and has held it in 4 quarters since.
  • 211 funds tracked by Wall St. Rank held Arteris as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.